Coya Therapeutics Inc.
COYA | NASDAQ
$4.95
+$0.06 (+1.23%)
At close: Sep 21, 2026, 4:00 PM ET
$4.95
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 7.95M | 3.55M | 6M | n/a | n/a | n/a |
Cost of Revenue | 27.36K | 11.87M | 5.5M | 4.41M | n/a | n/a |
Gross Profit | 7.92M | -8.31M | 500.68K | -4.41M | n/a | n/a |
Operating Income | -20.27M | -17.25M | -7.9M | -9.81M | -4.87M | -1.04M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -21.22M | -15.6M | -7.26M | -12.24M | -4.89M | -1.1M |
Net Income | -21.23M | -14.88M | -7.99M | -12.24M | -4.89M | -1.1M |
Selling & General & Admin | 11.45M | 8.89M | 7.83M | 4.85M | 2.31M | 668.7K |
Research & Development | 16.73M | 11.89M | 6.04M | 4.94M | 2.54M | 373.45K |
Other Expenses | n/a | -11.84M | -5.47M | -4.39M | 16.13K | n/a |
Operating Expenses | 28.18M | 8.94M | 8.4M | 5.4M | 4.87M | 1.04M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 38.98K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.21M | 20.8M | 13.91M | 9.81M | 4.87M | 1.04M |
Income Tax Expense | 3.09K | -720.29K | 723.85K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 16.73M | 15.24M | 10.16M | 9.95M | 6.6M | 2.59M |
Shares Outstanding (Diluted) | 16.73M | 15.24M | 10.16M | 9.95M | 6.6M | 2.59M |
EPS (Basic) | -1.27 | -0.98 | -0.79 | -1.23 | -0.74 | -0.42 |
EPS (Diluted) | -1.27 | -0.98 | -0.79 | -1.23 | -0.74 | -0.42 |
EBITDA | -21.2M | -17.2M | -7.33M | -9.26M | -4.88M | n/a |
EBIT | -21.22M | -17.22M | -7.36M | -9.29M | -4.89M | -704.65K |
Depreciation & Amortization | 27.36K | 27.36K | 27.36K | 27.36K | 16.13K | 704.65K |
Add to Watchlist
Select watchlists to add or remove COYA